2025 Liver session (ENDURING)
In support of improving patient care, Duke University Health System Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team. The designation was based upon the quality of the educational activity and its compliance with the standards and policies of the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC).

Program Description: The Southeast Regional Transplant Summit (the "Summit") brings together leaders in the field of transplantation to share the latest scientific advances in the perioperative care of solid organ transplant patients. The Summit strives to facilitate the multidisciplinary adoption of new research results and practice guidelines in kidney, liver, lung, and pediatric multi-organ transplantation. The Summit features didactic and video-based presentations on current research as well as interactive debates and discussions of interesting and challenging case studies. Participants will engage in question-and-answer sessions and learn from transplantation experts. Afternoon organ-specific breakout sessions are available for focused learning. The Summit's enduring content is a unique program that is affordable, accessible, and tailored to meet the demands of today's busy healthcare providers.
Target Audience
Allied Health Professionals
Fellows
Medical Students
Nurses
Nurse Practitioners
Physicians
Physician Assistants
Pharmacists
Learning Objectives
- Outlining potential ways to use AI and data science to improve the liver transplant selection process
- Discussing key concepts related to AI-assisted decision making
- Describing the burden of CHD in liver and kidney transplant candidates and its impact on outcomes
- Discuss goals and controversies of CHD screening in LT and KT candidates
- Exploring updates in liver transplant oncology
Lisa VanWagner, MD, MSc, FAST, FAHA, FAASLD - Has ineligible financial relationships to disclose: Advisory Board Madrigal pharmaceuticals, Research (enrolling site coinvestigator) Madrigal Pharmaceuticals, Research (enrolling site coinvestigator) Akero, Research (investigator-initiated), money paid to institution, W.L. Gore & Associates
Patrick Tam, FRACP, MBBS, MPH - No ineligible financial relationships to disclose
Omobonike Oloruntoba, MD - No ineligible financial relationships to disclose
Aly Strauss, MD, MIE - No ineligible financial relationships to disclose
ACPE - Pharmacist
AMA PRA Category 1 Credit(s)
ANCC
IACET CEU
JA Credit - AH
Available Credit
- 2.00 ACPE - Pharmacist
- 2.00 AMA PRA Category 1 Credit(s)™
- 2.00 ANCC
- 2.00 Attendance
- 0.20 IACET CEU
- 2.00 JA Credit - AH

Facebook
X
LinkedIn
Forward